Given the ongoing discord within the scientific community regarding the short-term and long-term efficacy and safety of the different types of anti-SARS-CoV-2 vaccines, their experimental nature, and the availability of other therapeutic approaches,[1] such information should be universal and should be provided to every potential vaccine recipient. The safety and tolerance of COVID-19 vaccines must be carefully considered and studied even when the benefits may outweigh the disadvantages.[2]
